Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

ABSTRACT: Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

PROVIDER: PRJEB19635 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1855450_1.fastq.gz	Fastqsanger.gz
	ERR1855450_2.fastq.gz	Fastqsanger.gz
	ERR1855445_1.fastq.gz	Fastqsanger.gz
	ERR1855445_2.fastq.gz	Fastqsanger.gz
	ERR1855446_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

Project description:Summary: Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) protein. It is localized in cytosol and binds to pancreatic-type ribonucleases and inhibit their function. However, the entire biological role for Rnh1 is unknown. We generated RNH1 knock out K562 cells by CRISPR/Cas9 method. Here we studied differential gene expression from wild type and RNH1 knock out K562 cells by RNA-Seq analysis. Overall design: Total RNA was isolated from wild type and RNH1 deficient K562 cells.

2017-03-05 | E-MTAB-5162 | biostudies-arrayexpress

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

Project description:Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) protein. It is localized in cytosol and binds to pancreatic-type ribonucleases and inhibit their function. However the entire biological role for Rnh1 is unknown. We generated Rnh1 knock out mice by homologous recombination. Here we studied differential gene expression from wild type (Rnh1 +/+), Heterozygous (Rnh1+/-) and Knock out (Rnh1-/-) yolk sacs isolated from embryonic day 9.5 (E9.5). We used microarrays to study global gene expression regulated by Rnh1 in yolk sacs.

2013-07-01 | GSE48146 | GEO

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

2013-07-01 | E-GEOD-48146 | biostudies-arrayexpress

Regulation of mRNA translation by RNH1 in hematopoietic cells

Project description:Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) containing protein. It binds to pancreatic-type ribonucleases and inhibit their function. However, the entire biological role of Rnh1 is unknown. We generated RNH1 knock out K562 cells by CRISPR/Cas9 method. We isolated polysomal RNA from control and RNH1-deficient K562 cells to quantify actively translated mRNAs by RNA-seq.

2024-03-20 | GSE237169 | GEO

E-MTAB-5162

Project description:Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

2025-01-23 | E-MTAB-5162 | ExpressionAtlas

Mus musculus

Project description:Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

| PRJNA208999 | ENA

Transcriptome profiling of NGLY1 deficient K562 cells

Project description:Transcriptome profiling of NGLY1 deficient K562 cells

| PRJEB37082 | ENA

Babesia microti strain RI strain:RI

Project description:Babesia microti strain RI strain:RI Genome sequencing

| PRJEA72411 | ENA

KMDR:K562 multi-drug resistance

Project description:To understand the underlying resistance mechanisms in response to imatinib (IMA) and adriamycin (ADR), the parental K562 cells were treated with low doses of IMA or ADR for two months to generate derivative cells with mild, intermediate and severe resistance to the drugs as defined by their increasing resistance index (RI). PulseDIA-based quantitative proteomics was then employed to reveal the proteome changes in these resistant cells

2021-12-21 | PXD030553 |

CNV profile in HSP90 inhibitor resistant K562 cells

Project description:Analysis of the acquired copy number profile in K562 cell which got resistant against HSP90 inhibitors.

| EGAS00001006385 | EGA